Stimulate the Face to Improve Tactile Acuity on the Hand (FACEHAND)

February 5, 2021 updated by: Hospices Civils de Lyon

Using a New Form of Cross-border Plasticity Within the Somatosensory Cortex: Stimulate the Face to Improve Tactile Acuity on the Hand

The study is a comparative study, to show that the administration of RSS stimulation on the face compared to the administration of strategy Sham stimulation, results in an temporary improvement in the tactile acuity of the hand in patients with tactile acuity impairment of the hand due to stroke.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-Genis-Laval, France, 69230
        • Groupement Hospitalier du Sud - Hôpital Henry Gabrielle

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age: 30-80 years old
  • Patients with diagnosis of unilateral (both right and left) ischemic or haemorrhagic stroke
  • Stroke event dates at least 3 months before the date of inclusion to the study
  • Mild-to-moderate sensory loss at the fingers of the hand contralateral to the stroke lesion (affected hand)
  • Capacity to provide written consent
  • Affiliation to a social security scheme

Non-Inclusion Criteria:

  • Sensory impairment attributable to diabetes history, peripheral vascular disease or neuropathy
  • Severe speech disorder, global aphasia and/or cognitive impairment
  • Multiple stroke events
  • Bilateral stroke event
  • Hemineglect
  • History of neurological or psychiatric illness
  • Allergy to glue/tape
  • Male participants refusing to shave their moustaches or beards during the study
  • Other experimental procedure is forbidden during the weeks where the study is performed
  • Pregnant, parturient and lactating women
  • Persons deprived of their liberty
  • Adult persons subject to a legal protection measure: guardianship, curatorship
  • Congenital or acquired malformation/injury of the test finger

Exclusion Criteria:

  • Impossibility to maintain hand position necessary for the tests due to severe spasticity
  • Severe impairment of the sensibility of the face preventing the administration of the RSS
  • Severe impairment of the absolute touch detection at the affected hand preventing measurement (threshold 512 mN)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: RSS
Repetitive somatosensory stimulation (RSS)

Repetitive somatosensory stimulation (RSS) applied on a small region of the face for 3 hours

Sham Repetitive somatosensory stimulation (RSS) applied on a small region of the face for 3 hours : the number of stimuli is reduced compared to the effective RSS

Other Names:
  • Repetitive somatosensory stimulation (RSS)
  • Sham Repetitive somatosensory stimulation (RSS)
Placebo Comparator: Sham RSS
Sham Repetitive somatosensory stimulation (RSS)

Repetitive somatosensory stimulation (RSS) applied on a small region of the face for 3 hours

Sham Repetitive somatosensory stimulation (RSS) applied on a small region of the face for 3 hours : the number of stimuli is reduced compared to the effective RSS

Other Names:
  • Repetitive somatosensory stimulation (RSS)
  • Sham Repetitive somatosensory stimulation (RSS)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tactile acuity : 2 point discrimination test
Time Frame: Week 3

The Primary outcome measure is a composite of 2point discrimination test (2PDT) and Absolute threshold detection test after 3h of RSS.

Spatial discrimination of the finger, Absolute threshold detection of the finger.

Week 3
Tactile acuity : Absolute threshold detection test after 3h of RSS
Time Frame: Week 3

The Primary outcome measure is a composite of 2point discrimination test (2PDT) and Absolute threshold detection test after 3h of RSS.

Spatial discrimination of the finger, Absolute threshold detection of the finger.

Week 3

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Jebsen-Taylor hand function test (JTHFT)
Time Frame: Week 3
Overall functionality of the hand, especially with regard to handling objects
Week 3
Questionnaire comfort/ease to use
Time Frame: Week 3
A self-reported assessment will be administered after the completion of testing procedure: a custom-made questionnaire including the ease of use, perceived sensations during RSS, easy positioning, pain on removal, positive and negative aspects of RSS, willing to continue using after release from the hospital, and willing to recommend to others.
Week 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jacques LUAUTE, PU-PH, Service de Médecine Physique et Réadaptation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2021

Primary Completion (Anticipated)

February 1, 2021

Study Completion (Anticipated)

February 21, 2023

Study Registration Dates

First Submitted

January 26, 2021

First Submitted That Met QC Criteria

February 5, 2021

First Posted (Actual)

February 9, 2021

Study Record Updates

Last Update Posted (Actual)

February 9, 2021

Last Update Submitted That Met QC Criteria

February 5, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 69HCL20_0888
  • 2020-A03467-32 (Other Identifier: ID-RCB)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on RSS

3
Subscribe